Release Date: 24/02/11 09:19 Summary: Chairman's Address to Shareholders Price Sensitive: No Download Document 250.66KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%